Impact of metronidazole resistance on the eradication of Helicobacter pylori

Scandinavian Journal of Infectious Diseases
L A NoachG N Tytgat

Abstract

We investigated how often Helicobacter pylori was resistant to metronidazole before treatment in 283 H. pylori positive patients and whether the in vitro susceptibility to metronidazole could predict the clinical outcome of several drug regimens containing metronidazole. Metronidazole susceptibility was tested using either disc diffusion or plates containing metronidazole. Metronidazole-resistant strains were found in 41% of patients before their first anti-H. pylori treatment course. In patients with metronidazole-susceptible isolates, eradication was achieved in 74% after colloidal bismuth subcitrate (CBS) with metronidazole and in 91% after triple therapies consisting of CBS, metronidazole and amoxicillin or tetracycline. Dual therapies of 1 or 4 weeks' duration and triple therapies lasting 1 week were ineffective in patients with metronidazole-resistant strains. A 4-week course of triple therapy could still eradicate H. pylori in 68% of patients with metronidazole-resistant strains, but at the cost of significant side-effects. It is concluded that metronidazole resistance is common and is generally associated with a poor outcome of anti-H. pylori therapies containing metronidazole. Alternative drug schedules are urgently ne...Continue Reading

References

Jul 25, 1992·Lancet·R P LoganJ J Misiewicz
Feb 1, 1992·The Journal of Antimicrobial Chemotherapy·G CederbrantA Ljungh
Apr 1, 1992·Scandinavian Journal of Gastroenterology·T J BorodyM Walton
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·H RautelinT U Kosunen
Nov 16, 1991·Lancet·R P LoganJ H Baron
Jan 1, 1991·International Urology and Nephrology·J PeiserY Hertzanu
Mar 3, 1990·Lancet·M C BecxR W de Koning
Apr 21, 1990·Lancet·Y GlupczynskiD De Vos
Aug 6, 1990·The Medical Journal of Australia·L L GeorgeS Brandl
Dec 8, 1990·Lancet·J WeilP H Jones
Oct 16, 1989·The Medical Journal of Australia·T J BorodyL L George
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·E Bayerdörffer, R Ottenjann

❮ Previous
Next ❯

Citations

Jun 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T H HenriksenT Thoresen
Mar 12, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E RozynekJ Jeljaszewicz
Jan 1, 1996·Journal of Photochemistry and Photobiology. B, Biology·C E MillsonS G Bown
Mar 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·A E AniG A Rocha
Jul 2, 1999·International Journal of Antimicrobial Agents·T AlarcónM López-Brea
Jun 1, 1997·Alimentary Pharmacology & Therapeutics·A M SeguraD Y Graham
Apr 2, 1999·Alimentary Pharmacology & Therapeutics·J WermeilleA Hadengue
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·F S LehmannC Beglinger
Oct 12, 1995·The New England Journal of Medicine·J H Walsh, W L Peterson
Apr 1, 1997·Journal of Clinical Periodontology·T Larsen, N E Fiehn
Apr 22, 1999·Japanese Journal of Medical Science & Biology·C W LinK S Cheng
Apr 27, 1996·Lancet·P D MidoloJ R Lambert
Jan 29, 1999·Lancet·L TeareI Tiwari
Jun 10, 2000·Journal of Gastroenterology and Hepatology·E K TeoA L Tan
Mar 10, 2000·The American Journal of Gastroenterology·W A de BoerG N Tytgat
Mar 1, 1996·Helicobacter·R W van der HulstG N Tytgat
Jun 1, 1996·Helicobacter·M M YousfiD Y Graham
May 24, 2006·World Journal of Gastroenterology : WJG·Xiao-Hui HuoJun Yu
Oct 9, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K WolleW König
Aug 8, 2001·Archives of Biochemistry and Biophysics·M A JorgensenG L Mendz
Jun 1, 1997·Journal of Clinical Microbiology·T H HenriksenA Lia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.